MediWound director Fox acquires 6,534 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
MediWound Ltd. director David Morton Fox exercised Series A Warrants on November 10, 2026, for 6,534 ordinary shares at an exercise price of $13.475 per share. He paid the aggregate exercise price in cash and reported that he did not sell the shares acquired. No separate price was paid for the warrants. Fox also reported direct stock-option holdings, including options for 14,285 ordinary shares at $12.2500 and 6,250 at $17.6000; those holdings were included for informational purposes, not as transactions.
Insider Trade Summary
6,534 shares exercised/converted
Exercise
2 txns
Insider
Fox David Morton
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| In-the-Money Exercise | Series A Warrants F4 | 6,534 | -- | -- |
| In-the-Money Exercise | Ordinary Shares F4 | 6,534 | $13.475 | $88K |
| Holding | Stock Option (right to buy ordinary shares) F2 | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) F2 | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) F2 | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) F2 | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) F2 | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) F2 | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) F2, F3 | -- | -- | -- |
| Holding | Ordinary shares F1, F2 | -- | -- | -- |
Holdings After Transaction:
Series A Warrants — 0 warrants (Direct);
Ordinary shares — 29,567 shares (Direct);
Stock Option (right to buy ordinary shares) — 46,541 options (Direct)
Footnotes (4)
- F1. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
- F2. There were no transactions affected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- F3. The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
- F4. On November 10, 2026, the Reporting Person exercised Series A Warrants to purchase 6,534 ordinary shares at an exercise price of $13.475 per share, paying the aggregate exercise price in cash. The Reporting Person did not sell any of the ordinary shares acquired upon the exercise. No separate price was paid for the Series A Warrants upon exercise. The exercise price is reported in column 2 and in Table I.
Key Figures
Ordinary shares acquired: 6,534 shares
Warrant exercise price: $13.475 per share
Series A Warrants following exercise: 0 warrants
+3 more
6 metrics
Ordinary shares acquired
6,534 shares
Through the Series A Warrant exercise on November 10, 2026
Warrant exercise price
$13.475 per share
Series A Warrants exercised on November 10, 2026
Series A Warrants following exercise
0 warrants
Reported after the November 10, 2026 exercise
Underlying ordinary shares
14,285 shares
Direct stock options with a $12.2500 exercise price
Underlying ordinary shares
6,250 shares
Direct stock options with a $17.6000 exercise price
Underlying ordinary shares
5,357 shares
Direct stock options with a $14.4200 exercise price
Key Terms
Series A Warrants, exercise price, RSUs
3 terms
Series A Warrants financial
"exercised Series A Warrants to purchase 6,534 ordinary shares"
Series A warrants are financial tools that give the holder the right to buy shares of a company at a specific price within a certain period. They are often issued alongside investments to provide additional potential profit if the company's value increases. For investors, they can offer a chance to benefit from future growth without committing immediate capital to buying shares.
exercise price financial
"at an exercise price of $13.475 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
RSUs financial
"shares underlying RSUs that were granted to the Reporting Person"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Did David Morton Fox pay a separate price for the MDWD Series A Warrants?
No separate price was paid for the Series A Warrants upon exercise. The exercise price was $13.475 per share and was paid in cash.
AI-generated analysis. How Rhea-AI works. Not financial advice.
